Acute ischemic stroke. Cerebral infarction, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Routine treatment plus tissue plasminogen activator 0.9 mg/kg through intravenous infusion. Intervention 2: Control group: Just routine treatment.
Treatment - Drugs
Intervention group: Routine treatment plus tissue plasminogen activator 0.9 mg/kg through intravenous infusion.
Sponsors
Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age of 18 to 85 years; acute ischemic stroke. Exclusion criteria: A history of acute ischemic stroke in the past 3 months; using heparin or warfarin in the past 48 hours; a history of head trauma in the past 3 months; a history of intra cranial hemorrhage; a history of myocardial infarction in the past 3 months; gastric hemorrhage in the past 3 months; a history of major surgery in the past 2 weeks; a history of convulsion.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing the neurological signs. Timepoint: every 12 hours for 72 hours. Method of measurement: using NIHSS scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Ghadimi Farah
Sina Hospital
Outcome results
None listed